Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA374083
Max Phase: Preclinical
Molecular Formula: C50H49ClF5N7O9
Molecular Weight: 908.40
Molecule Type: Small molecule
Associated Items:
ID: ALA374083
Max Phase: Preclinical
Molecular Formula: C50H49ClF5N7O9
Molecular Weight: 908.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)CCC(=O)N1C/C(=C\c2ccccc2F)C(=O)/C(=C/c2ccccc2F)C1)C(=O)c1ccccc1)C(=O)CCl.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C48H48ClF2N7O7.C2HF3O2/c49-27-40(59)38(20-11-23-54-48(52)53)56-47(65)43(45(63)31-14-5-2-6-15-31)57-46(64)39(24-30-12-3-1-4-13-30)55-41(60)21-22-42(61)58-28-34(25-32-16-7-9-18-36(32)50)44(62)35(29-58)26-33-17-8-10-19-37(33)51;3-2(4,5)1(6)7/h1-10,12-19,25-26,38-39,43H,11,20-24,27-29H2,(H,55,60)(H,56,65)(H,57,64)(H4,52,53,54);(H,6,7)/b34-25+,35-26+;/t38-,39-,43+;/m1./s1
Standard InChI Key: OGZQEGKRRLPTTQ-MRBBKXDSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 908.40 | Molecular Weight (Monoisotopic): 907.3272 | AlogP: 4.27 | #Rotatable Bonds: 20 |
Polar Surface Area: 220.72 | Molecular Species: BASE | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.46 | CX Basic pKa: 11.89 | CX LogP: 4.12 | CX LogD: 2.40 |
Aromatic Rings: 4 | Heavy Atoms: 65 | QED Weighted: 0.01 | Np Likeness Score: -0.27 |
1. Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP.. (2006) Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system., 49 (11): [PMID:16722634] [10.1021/jm051141k] |
Source(1):